Growth Investors & VC Firms in Global

1481 firms in this list, with a median first check of $1M. 359 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
TU Tullis Health Investors JTJTBBDL12 people	88🔒	Palm Beach Gardens	US	Series A–Late Stage	$500K – $10M	+ Add to CRM
UN Unorthodox Ventures CSAKBSCA15 people	88🔒	Austin	US	Pre-Seed–Growth	$1M – $5M	+ Add to CRM
AM American Century Private Investments JTJBNWRM20 people	88🔒	Kansas City	US	Growth	—	+ Add to CRM
BA Baillie Gifford SCAFGSLK5 people · Follows rounds	88🔒	Edinburgh	GB	Series B–Late Stage	—	+ Add to CRM
QU Quadrille Capital APRSVBAG14 people	88🔒	Paris	FR	Seed–Late Stage	—	+ Add to CRM
CL Climate Investment CBJD2 people	88🔒	London	GB	Seed–Growth	—	+ Add to CRM
LI Lightrock AECSGVCC16 people	88🔒	London	GB	Pre-Seed–Growth	—	+ Add to CRM
MP MPower KMMSYMKD10 people	88🔒	—	JP	Pre-Seed–Late Stage	—	+ Add to CRM
PA PAI Partners AAKBAAWP13 people	88🔒	Paris	FR	Growth–Late Stage	$108M – $324M	+ Add to CRM
VI Vision Plus Capital EWACJWTT13 people · Follows rounds	88🔒	Hangzhou	CN	Seed–Growth	$6.5M – $130M	+ Add to CRM
AE AE Industrial Partners DHMGTC3 people	88🔒	Boca Raton	US	Growth–Late Stage	—	+ Add to CRM
CA Capital Cell	88🔒	Barcelona	ES	Pre-Seed–Growth	—	+ Add to CRM
CO CoastCap MTCNCPC6 people	88🔒	Vienna	AT	Seed–Late Stage	—	+ Add to CRM
BU Business Growth Fund AGASBJSP11 people · Follows rounds	88🔒	London	GB	Seed–Growth	$3.8M – $38M	+ Add to CRM
HI Hikma Ventures LGAFSAAA14 people · Leads rounds	88🔒	London	GB	Seed–Late Stage	$5M	+ Add to CRM
MA Mastry AIFHRSRC5 people	88🔒	San Francisco	US	Pre-Seed–Late Stage	—	+ Add to CRM
CL Clearvision Ventures AGFZSLTE11 people · Leads rounds	88🔒	Menlo Park	US	Pre-Seed–Late Stage	$1M – $25M	+ Add to CRM
DA Danone Manifesto Venture CDKSHJAC11 people	88🔒	New York City	US	Seed–Growth	—	+ Add to CRM
KH Khazanah Nasional AFHHACDA17 people	88🔒	Kuala Lumpur	MY	Growth–Late Stage	—	+ Add to CRM
IN Intermediate Capital Group BDAIASAL16 people	88🔒	London	GB	Growth–Late Stage	$5M – $50M	+ Add to CRM
MA Maxpro Ventures ACFCMCAC7 people	88🔒	Taipei	TW	Seed–Late Stage	$10M – $13M	+ Add to CRM
IN INCE Capital PKSZSHBD9 people · Follows rounds	88🔒	Shanghai	CN	Seed–Late Stage	—	+ Add to CRM
IP IPR.VC TTTAASKS15 people · Follows rounds	88🔒	Helsinki	FI	Seed–Growth	$27K – $1.1M	+ Add to CRM
SA Sandbridge Capital DDKSTHWC11 people	88🔒	Los Angeles	US	Seed–Late Stage	$10M – $20M	+ Add to CRM

Tullis Health Investors

Palm Beach GardensSeries A–Late Stage$500K – $10M

JTJTBBDL12 people

Unorthodox Ventures

AustinPre-Seed–Growth$1M – $5M

CSAKBSCA15 people

American Century Private Investments

Kansas CityGrowth

JTJBNWRM20 people

Baillie Gifford

EdinburghSeries B–Late Stage

SCAFGSLK5 people

Quadrille Capital

ParisSeed–Late Stage

APRSVBAG14 people

Climate Investment

LondonSeed–Growth

CBJD2 people

Lightrock

LondonPre-Seed–Growth

AECSGVCC16 people

MPower

Pre-Seed–Late Stage

KMMSYMKD10 people

PAI Partners

ParisGrowth–Late Stage$108M – $324M

AAKBAAWP13 people

Vision Plus Capital

HangzhouSeed–Growth$6.5M – $130M

EWACJWTT13 people

AE Industrial Partners

Boca RatonGrowth–Late Stage

DHMGTC3 people

Capital Cell

BarcelonaPre-Seed–Growth

CoastCap

ViennaSeed–Late Stage

MTCNCPC6 people

Business Growth Fund

LondonSeed–Growth$3.8M – $38M

AGASBJSP11 people

Hikma Ventures

LondonSeed–Late Stage$5M

LGAFSAAA14 people

Mastry

San FranciscoPre-Seed–Late Stage

AIFHRSRC5 people

Clearvision Ventures

Menlo ParkPre-Seed–Late Stage$1M – $25M

AGFZSLTE11 people

Danone Manifesto Venture

New York CitySeed–Growth

CDKSHJAC11 people

Khazanah Nasional

Kuala LumpurGrowth–Late Stage

AFHHACDA17 people

Intermediate Capital Group

LondonGrowth–Late Stage$5M – $50M

BDAIASAL16 people

Maxpro Ventures

TaipeiSeed–Late Stage$10M – $13M

ACFCMCAC7 people

INCE Capital

ShanghaiSeed–Late Stage

PKSZSHBD9 people

IPR.VC

HelsinkiSeed–Growth$27K – $1.1M

TTTAASKS15 people

Sandbridge Capital

Los AngelesSeed–Late Stage$10M – $20M

DDKSTHWC11 people

Data sourced from public filings and firms' own websites — see our methodology.